NephroStem

N/A

Report date: 2025/03/20 14:57:13

Base Information

Drug NameNephroStem
Drug Alias Namemesenchymal stem cell therapy (Amniotics)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRenal InsufficiencyGlomerulonephritis, Membranoproliferative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmniotics AB
China Registration ClassN/A

Develop Information

Active CompaniesAmniotics AB
Inactive CompaniesN/A
Active IndicationsRenal InsufficiencyGlomerulonephritis, Membranoproliferative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A